Conditions: Hypertension
Allocation:  | Intervention model: PARALLEL
Enrollment: 314
Healthy volunteers: no

Brief summary:
The primary purpose of this study is to:

Demonstrate that a fixed-dose combination of telmisartan 40 mg plus amlodipine 5 mg is superior to telmisartan 40 mg alone in patients with essential hypertension and inadequately controlled with telmisartan 40 mg monotherapy.

Detailed description:

Arms:

Interventions: intervention 1: telmisartan+amlodipine intervention 2: telmisartan
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: